Nearly 44% of primary care visits for Medicare fee-for-service beneficiaries were telehealth visits in April, up from 0.1% in February, according to a report released this week by the Department of Health and Human Services.

Medicare fee-for-service telehealth visits for primary care climbed from about 14,000 per week before the COVID-19 pandemic to 1.3 million per week in April, HHS said.

The Centers for Medicare & Medicaid Services has waived Medicare geographic and originating site restrictions on telehealth and expanded the list of telehealth-eligible services and practitioners during the emergency.

HHS Secretary Alex Azar said the report “shows that Medicare providers and beneficiaries rapidly embraced these new opportunities. The meteoric rise of telehealth during the pandemic has not only helped us combat the virus, but also prompted a new conversation around the future of patient-centered care."

AHA has urged Congress and the Administration to ensure flexibilities remain in place after the public health emergency, as well as to reimburse virtual services on par with in-person care. For more information, see the new AHA factsheet on the future of telehealth.

Headline
In this conversation, Jeremy Cauwels, M.D., chief medical officer at Sanford Health, shares how the nation’s largest rural health system is using a $350…
Headline
The American Medical Association Nov. 17 released its latest annual report on health insurance competition, which found that 95% of commercial markets were…
Headline
The Medicare Part A deductible for inpatient hospital services will increase by $40 in calendar year 2026 to $1,776, the Centers for Medicare & Medicaid…
Headline
The Centers for Medicare & Medicaid Services Nov. 16 issued a proposed rule on program integrity oversight in Medicare, Medicaid, the Children’s Health…
Headline
The Centers for Medicare & Medicaid Services Nov. 5 published a final rule to codify the Medicare Drug Price Negotiation Program beginning in 2029. The…
Headline
The estimated average monthly premium for Medicare Part D stand-alone prescription drug plans is $51 for 2027, a 50% increase from $34 in 2026, for enrollees…